Currently set to Index
Currently set to Follow
search
ask age2b
CART 0

The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials

By AGE2B team
July 1, 2021
0
0

Main idea: Generally, probiotics may be safe and may improve whole gut transit time, stool frequency, and stool consistency. However, adequately powered RCTs are required to better determine the species or strains, doses, and duration of use of probiotics that are most efficacious. Further research and evidence are required before probiotics are adopted as one of the treatments of IBS-C.

Abstract

Constipation-predominant irritable bowel syndrome (IBS-C) is a functional bowel disorder that may involve disturbance of the gastrointestinal microbiota. Seventeen RCTs involving 1469 patients were included in the analysis. Overall, probiotics significantly increased stool frequency by 1.29 bowel movements (BM)/wk, and improved stool consistency. Compared with placebo, patients using probiotics experienced a shorter gut transit time by 12.36 h. No serious adverse events were reported.

Source ScienceDirect

Leave a Reply

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.